» Authors » Jona Saemundsdottir

Jona Saemundsdottir

Explore the profile of Jona Saemundsdottir including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 50
Citations 6887
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kjaersgaard Andersen R, Stefansdottir L, Riis P, Halldorsson G, Ferkingstad E, Oddsson A, et al.
J Am Acad Dermatol . 2024 Dec; PMID: 39645042
Background: The contributions of genetic and environmental risk factors to hidradenitis suppurativa (HS) are both poorly understood. Objective: To identify sequence variants that associate with HS and determine the contribution...
2.
Oddsson A, Steinthorsdottir V, Oskarsson G, Styrkarsdottir U, Moore K, Isberg S, et al.
Nat Genet . 2024 Aug; 56(9):1804-1810. PMID: 39192094
Age at menopause (AOM) has a substantial impact on fertility and disease risk. While many loci with variants that associate with AOM have been identified through genome-wide association studies (GWAS)...
3.
Hjorleifsson Eldjarn G, Ferkingstad E, Lund S, Helgason H, Magnusson O, Gunnarsdottir K, et al.
Nature . 2024 May; 630(8015):E3. PMID: 38778117
No abstract available.
4.
Jensson B, Arnadottir G, Katrinardottir H, Fridriksdottir R, Helgason H, Oddsson A, et al.
N Engl J Med . 2023 Nov; 389(19):1741-1752. PMID: 37937776
Background: In 2021, the American College of Medical Genetics and Genomics (ACMG) recommended reporting actionable genotypes in 73 genes associated with diseases for which preventive or therapeutic measures are available....
5.
Bjornsdottir G, Chalmer M, Stefansdottir L, Skuladottir A, Einarsson G, Andresdottir M, et al.
Nat Genet . 2023 Oct; 55(11):1843-1853. PMID: 37884687
Migraine is a complex neurovascular disease with a range of severity and symptoms, yet mostly studied as one phenotype in genome-wide association studies (GWAS). Here we combine large GWAS datasets...
6.
Hjorleifsson Eldjarn G, Ferkingstad E, Lund S, Helgason H, Magnusson O, Gunnarsdottir K, et al.
Nature . 2023 Oct; 622(7982):348-358. PMID: 37794188
High-throughput proteomics platforms measuring thousands of proteins in plasma combined with genomic and phenotypic information have the power to bridge the gap between the genome and diseases. Here we performed...
7.
Helgason H, Eiriksdottir T, Ulfarsson M, Choudhary A, Lund S, Ivarsdottir E, et al.
JAMA . 2023 Aug; 330(8):725-735. PMID: 37606673
Importance: Whether protein risk scores derived from a single plasma sample could be useful for risk assessment for atherosclerotic cardiovascular disease (ASCVD), in conjunction with clinical risk factors and polygenic...
8.
Magnusson M, Agnarsson B, Jonasson J, Tryggvason T, Aeffner F, le Roux L, et al.
Br J Cancer . 2023 Aug; 129(7):1142-1151. PMID: 37596405
Background: The TNM system is used to assess prognosis after colorectal cancer (CRC) diagnosis. Other prognostic factors reported include histopathological assessments of the tumour, tumour mutations and proteins in the...
9.
Holm H, Ivarsdottir E, Olafsdottir T, Thorolfsdottir R, Eythorsson E, Norland K, et al.
Commun Med (Lond) . 2023 Jul; 3(1):94. PMID: 37414856
Background: Persistent symptoms are common after SARS-CoV-2 infection but correlation with objective measures is unclear. Methods: We invited all 3098 adults who tested SARS-CoV-2 positive in Iceland before October 2020...
10.
Oddsson A, Sulem P, Sveinbjornsson G, Arnadottir G, Steinthorsdottir V, Halldorsson G, et al.
Nat Commun . 2023 Jul; 14(1):3923. PMID: 37400429
No abstract available.